Poland· PL-100379730

Camlocor

A candesartan und amlodipin product containing candesartanum cilexetili + amlodipinum, registered in Poland by Krka, d.d., Novo mesto. The same ATC class is registered in 6 of our 19 countries.

ATC C09DB07

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedCamlocorATCC09DB07REGISTER NO.PL-100379730PACKS LISTED22CHECKEDSeptember 27, 2026

Where it is registered

Candesartan und amlodipin is registered in 6 of 19 countries.

Countries holding a registration under ATC C09DB07 (candesartan und amlodipin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose

Candesartan und amlodipin · ATC C09DB07

6 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Italyprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Candesartanum cilexetili + Amlodipinum
Manufacturer
Krka, d.d., Novo mesto
Country
Poland (PL)
ATC code
C09DB07
ATC class
Candesartan und Amlodipin
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 22

1 priced
  • gtin
    05909991367497
  • gtin
    05909991367503
  • gtin
    05909991367633
  • gtin
    05909991367640
  • gtin
    05909991367657
  • gtin
    05909991367510
    28 szt.
    PLN 12.87
  • gtin
    05909991367459
  • gtin
    05909991367466
  • gtin
    05909991367473
  • gtin
    05909991367480
  • gtin
    05909991367527
  • gtin
    05909991367534
  • gtin
    05909991367541
  • gtin
    05909991367558
  • gtin
    05909991367565
  • gtin
    05909991367572
  • gtin
    05909991367589
  • gtin
    05909991367596
  • gtin
    05909991367602
  • gtin
    05909991367619
  • gtin
    05909991367626
  • gtin
    05909991367664

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

8 interactions on record for candesartan und amlodipin.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Candesartan und amlodipin · interactions on record

8 records

8 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e8b77e0c-6927-456c-be16-92e31dad6bce
GET /v1/drugs/e8b77e0c-6927-456c-be16-92e31dad6bce?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "8 mg + 5 mg",
  "packaging": "05909991367459 ¦ Rp ¦ Skasowane ¦ 127405\n7 tabl. w blistrze perforowanym\n05909991367466 ¦ Rp ¦ Skasowane ¦ 127406\n7 tabl. w blistrze\n05909991367473 ¦ Rp ¦ Skasowane ¦ 127407\n10 tabl. w blistrze\n05909991367480 ¦ Rp ¦ Skasowane ¦ 127408\n10 tabl. w blistrze perforowanym\n05909991367497 ¦ Rp ¦ Skasowane ¦ 127409\n14 tabl. w blistrze perforowanym\n05909991367503 ¦ Rp ¦ Skasowane ¦ 127410\n14 tabl. w blistrze\n05909991367510 ¦ Rp ¦ 127411\n28 tabl. w blistrze\n05909991367527 ¦ Rp ¦ 127412\n28 tabl. w blistrze perforowanym\n05909991367534 ¦ Rp ¦ 127413\n30 tabl. w blistrze\n05909991367541 ¦ Rp ¦ 127414\n30 tabl. w blistrze perforowanym\n05909991367558 ¦ Rp ¦ 127415\n50 tabl. w blistrze\n05909991367565 ¦ Rp ¦ 127416\n50 tabl. w blistrze perforowanym\n05909991367572 ¦ Rp ¦ 127417\n56 tabl. w blistrze\n05909991367589 ¦ Rp ¦ 127418\n56 tabl. w blistrze perforowanym\n05909991367596 ¦ Rp ¦ 127419\n60 tabl. w blistrze\n05909991367602 ¦ Rp ¦ 127420\n60 tabl. w blistrze perforowanym\n05909991367619 ¦ Rp ¦ 127421\n90 tabl. w blistrze\n05909991367626 ¦ Rp ¦ 127422\n90 tabl. w blistrze perforowanym\n05909991367633 ¦ Rp ¦ 127423\n98 tabl. w blistrze\n05909991367640 ¦ Rp ¦ 127424\n98 tabl. w blistrze perforowanym\n05909991367657 ¦ Rp ¦ 127425\n100 tabl. w blistrze\n05909991367664 ¦ Rp ¦ 127426\n100 tabl. w blistrze perforowanym",
  "substance": "Candesartanum cilexetili 8 mg + Amlodipinum 5 mg",
  "common_name": "Candesartanum cilexetili + Amlodipinum",
  "pl_product_id": "100379730",
  "pozwolenie_nr": "24633",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}

See everything about candesartan und amlodipin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.